Skip to Content

Genenta presents the company overview at the Access China Forum 2020

Jul 30, 2020

MILANO (Italy) / NEW YORK (NY, USA) — Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer (Temferon™), announced that they will present the corporate overview at the ACCESS CHINA Forum 2020, Summer Online Partnering Day, hosted by YAFO Capital Life Science.

Pierluigi Paracchi, Founder, Chairman and CEO of Genenta, will present the immune-gene therapy technology for tumors treatment, ongoing clinical trials, and company’s strategy on July 31, at 11:30am CET.

Free Registration at: